Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Receivables (2022 - 2025)

Historic Receivables for Jin Medical International (ZJYL) over the last 4 years, with Q1 2025 value amounting to $4.4 million.

  • Jin Medical International's Receivables rose 1159.51% to $4.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $4.4 million, marking a year-over-year increase of 1159.51%. This contributed to the annual value of $6.1 million for FY2024, which is 7732.53% up from last year.
  • Jin Medical International's Receivables amounted to $4.4 million in Q1 2025, which was up 1159.51% from $6.0 million recorded in Q3 2024.
  • Jin Medical International's Receivables' 5-year high stood at $8.7 million during Q1 2023, with a 5-year trough of $3.4 million in Q3 2023.
  • Over the past 4 years, Jin Medical International's median Receivables value was $4.2 million (recorded in 2022), while the average stood at $5.1 million.
  • Data for Jin Medical International's Receivables shows a peak YoY increase of 7494.77% (in 2024) and a maximum YoY decrease of 5515.04% (in 2024) over the last 5 years.
  • Jin Medical International's Receivables (Quarter) stood at $4.0 million in 2022, then dropped by 13.24% to $3.4 million in 2023, then surged by 74.95% to $6.0 million in 2024, then fell by 27.23% to $4.4 million in 2025.
  • Its Receivables was $4.4 million in Q1 2025, compared to $6.0 million in Q3 2024 and $3.9 million in Q1 2024.